Skip to main content
. Author manuscript; available in PMC: 2023 Jul 1.
Published in final edited form as: Female Pelvic Med Reconstr Surg. 2022 Apr 28;28(7):452–460. doi: 10.1097/SPV.0000000000001193

Table 1.

Number of Medical Device Reports by Mesh Product Name

Transvaginal Prolapse Mesh Products Midurethral Sling Mesh Products
n= 10,275 n (%) n= 20,936 n (%)
Gynecare Prolift and Prolift+Ma 6334 (61.6%) Transobturator
Uphold Liteb 2072 (20.2%) Gynecare Obturatora 11604 (55.4%)
Avaulta Solo and 1115 (10.9%) Gynecare Abbrevoa 437 (2.1%)
Plus/Biosyntheticc Arise 48 (0.2%)
Apogee/Perigeed 723 (7.0%) Retropubic
Exair APRe 26 (0.3%) Gynecare TVTa 5444 (26.0%)
Ascendf 5 (<0.1%) Advantage Fitb 1063 (5.1%)
Gynecare TVT Exacta 667 (3.2%)
Sacrocolpopexy Mesh Products Suprise 86 (0.4%)
n= 3,319 n (%) Either approach
Gynecare Gynemesha 2056 (61.9%) Desara Bluef 673 (3.2%)
Restorellee 1168 (35.2%) Single Incision
Upsylonb 64 (1.9%) Solyx SISb 552 (2.6%)
Artisyna 31 (0.9%) Altis SISe 362 (1.7%)
a

Ethicon, Bridgewater NJ

b

Boston Scientific, Marlborough MA

c

Bard Medical, Covington GA

d

American Medical Systems, Minnetonka MN

e

Coloplast, Humlebaek Denmark

f

Caldera Medical, Agoura Hills CA

N describes number of reports in the Manufacturer and User Facility Device Experience database, and percentage given is out of all reports for a given mesh type (transvaginal; sacrocolpopexy; Midurethral slings).

Due to the large number of possible multiple comparisons, transabdominal prolapse mesh and midurethral slings were limited to currently available products.

Gynecare Prolift and Prolift+M, although different meshes, are grouped together by the Reed Tech Navigator, as are Avaulta Solo and Avaulta Plus/Biosynthetic.